American Association for Cancer Research, Cancer Discovery, 3(8), p. 272-275, 2018
DOI: 10.1158/2159-8290.cd-18-0091
Full text: Download
Abstract Summary: Two reports in this issue of Cancer Discovery outline how the genomic composition of tumors, including the presence of intragenic gene fusions, could inform the selection of treatment approaches in aggressive forms of the disease. Cancer Discov; 8(3); 272–5. ©2018 AACR. See related article by Matissek et al., p. 336. See related article by Liu et al., p. 354.